We at Vironova are delighted to have entered into a collaboration with Testa Center in Uppsala, Sweden! Testa Center is a GE Healthcare subsidiary (GE owns 100%) and a separate business entity running as non-profit and with legal autonomy.
BPI West, 9-12 March, Santa Clara, California, US
Bioprocessing Summit Europe, 24-26 March, Barcelona, Spain, Europe
4th Annual Gene Therapy for rare disorders, 30 March April 2, Boston, MA, US
BPI EU Summit, 28 April-1 May, Amsterdam, Europe
Biotherapeutics Analytical Summit, 1-5 June, Alexandria, Virginia, US
2nd Annual Gene and Cell Therapy, 3-4 June, Munich, Germany, Europe
EMC2020: European Microscopy Congress, 23-28 August, Copenhagen, Europe
Bioprocessing Summit Boston, 24-28 August, Boston, MA, US
29-30 January, Washington, USA
Bacteriophages are a promising alternative treatment to (antimicrobial resistant) bacterial infections. In our poster, we show the potential of MiniTEM™ can be applied for quality analysis of phage preparations.
Poster presentation by Vanessa Carvalho, senior scientist Vironova
2-8 Feb 2019, Luxembourg, Europe
Vironova is a sponsor and is represented by Ida-Maria Sintorn at the Neubias conference together with core facility representatives, microscopists, and image analysts from all over Europe.
March 4-6, Norfolk,Virginia, USA
Technology Workshop by Vironova's Ph. D. and Director of EM Services, Josefina Nilsson. March 4th at 11:30 on the topic - Optimized Quantification Methods to Determine the Portion of Full AAV Capsids and Avoid Empty and Disrupted Particles.
For more information on the presentation, please contact josefina.nilsson@vironova.com
March 5-7, Stockholm, Sweden, EU
Vironova Biosafety will be attending The Biologics World Nordics in Stockholm to follow key industry trends, and network together with peers from biologics industry and academia.
Make sure to network with our Vironova Biosafety team at the conference. For more information please contact Vironova's Biosafety Director lennart.lindqvist@vironova.com
March 19-21, Lisbon, Portugal, EU
Round table hosted by Vironova's Marketing Director Nina Forsberg, 19th of March at 16:45. Presentation by Senior Scientist Vanessa Carvalho. on March 20th, at 15:15 on the topic - Analysis of Purity and Packaging of Gene Therapy Vectors and VLPs to Support Process Development Decisions.
Be sure to join the Round Table session, and meet our Sales Development Managers in booth 26.
For more information on the presentation, please contact vanessa.carvalho@vironova.com
March 31 - April 4, Orlando, Florida, USA
There will be a presentation by Vironova's Director of Instruments, Jonathan Royce on April 1st at 11:10 in Salon 6, Rosen Centre Hotel on the topic - BIOT 105: Automated characterization of gene therapy viral vectors: packaging, purity and integrity using transmission electron microscopy.
For more information on the presentation, please contact jonathan.royce@vironova.com and be sure not to miss the chance to network with our US Sales Development Manager Chris Bishop.
April 2-4, Vienna, Austria, EU
Vironova's Senior Scientist Mathieu Colomb-Delsuc will be giving a presentation on April 3rd at 12:30 on the topic - Purity analysis of gene therapy vectors from process development to commercial process.
Make sure to visit the Vironova team in the booth during the conference.
For more information on the presentation, please contact mathieu.colomb-delsuc@vironova.com
April 10th, at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Join our webinar and learn how MiniTEM transforms visual evidence into quantitative data that confirms critical quality attributes of viral products. Rapid results on purity and integrity allow process adjustments without unnecessary delays.
Speakers:
Vanessa Carvalho - Senior Scientist and Gustaf Kylberg - Senior Research Scientist.
April 10-12, Shenzhen, China
Vironova has been prequalified and will participate in the "Third China Innovation & Entrepreneurship International Competition", which aims to integrate innovation and entrepreneurship resources and help over 100 foreign innovation and entrepreneurship projects to connect with Chinese hi-tech industrial resources and expand the Chinese market for mutual benefits and win-win results.
For more information contact mohammed.homman@vironova.com
May 15-17, London, UK, EU
There will be a presentation by Vironova's Director of EM Services, Josefina Nilsson on May 16 at 16:25 on the topic - Accurate purity data in time helps to avoid late surprises when scaling up. Automated TEM analysis data of gene therapy vectors and VLPs
Be sure to visit the Vironova team in the booth at the conference. For more information on the presentation, please contact josefina.nilsson@vironova.com
The Annual General Meeting of Vironova AB was held on Monday 24 June 2019 at 15.00, at the Company's premises, Gävleatan 22, Stockholm.
July 1-4, Manchester, UK, EU
Vironova will be attending MMC19, arranged by the UK based charity the Royal Microscopical Society, to follow key industry trends, and network together with peers and experts from the microscopy and imaging field.
Be sure to find time to chat with Vironova Sales Development Manager Antonio Ballisai at the congress. For more information please contact Vironova's Sales and Marketing Director ulf.danielsson@vironova.com
August 12-16, Boston, USA
Presentation by Senior Scientist Vanessa Carvalho. on August 14 , at 11.45 on the topic - Meaningful Analytics data for quick decision making in the development of viral vector based therapies
Be sure to meet our Sales Development Managers in booth 139.
For more information on the presentation, please contact vanessa.carvalho@vironova.com
Feel free to reach out to our booth staff: business development managers Chris Bishop chris.bishop@vironova.com and Ulla Sundberg, Ulla.Sundberg@vironova.com and sales director Ulf Danielsson, ulf.danielsson@vironova.com
September 12-16, Boston, USA
Vironova will attend and be a part of the leading Biotech event, interacting with the best scientific minds and business leaders in Boston and from all around the world.
Feel free to reach out to our US Business Development Manager Chris Bishop chris.bishop@vironova.com and Biosafety Director Lennart Lindqvist, lennart.lindqvist@vironova.com who will be attending the conference.
Thursday, September 26, 2019
Understand how artificial intelligence can address challenges in viral particle sample analysis
Speakers: Josefina Nilsson, Head of EM services and Ida-Maria Sintorn, CTO Vironova
October 8-10, 2019 | Las vegas, NV
We are honored to have won the "Enterprise Business Transformation" category. Now moving forward to the People´s choice finals in Hitachi´s Transformation Awards in Las Vegas. The award go to organizations that have accelerated their digital transformation with support from Hitachi Group solutions - having the insights and innovation to win today and tomorrow!
Vironova will be represented in the competition by Martin Ryner, Strategic development, and Mats Henriksson CRO.
November 19-21, 2019 | Boston, MA
Vironova will attend and be a part of the leading summit with focus to overcoming the unique analytical challenges encountered in the gene therapy space, interacting with the best scientific minds and business leaders in Boston and from all around the world.
Our Head of EM Services, Josefina Nilsson will on Thursday 21st October be presenting "How TEM Based Image Analysis Can Reveal Process Impact on Critical Quality Attributes".
Feel free to reach out to our US Business Development Manager Chris Bishop chris.bishop@vironova.com and who will be attending the conference.
December 3-6 | Amsterdam, EU
Join Vironova at #cellgene in Amsterdam, where our Senior Scientist, PhD, and microscopist Vanessa Carvalho will be presenting "How TEM based image analysis can reveal process impact on critical quality attributes". We are excited to attend and be a part of the leading summit with focus to overcoming the unique analytical challenges encountered in the cell therapy manufacturing space, interacting with the best scientific minds and business leaders in Boston and from all around the world.
Join us on social media
© Copyright Vironova 2020, all rights reserved
